You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
廣濟藥業(000952.SZ)擬斥2000萬元設立全資子公司 實現“原料藥+製劑”兩輪驅動
格隆匯 12-17 15:50

格隆匯12月17日丨廣濟藥業(000952.SZ)公佈,為加強制劑業務板塊整合,提高資產運行效率,提升製劑產品市場競爭力,實現“原料藥+製劑”兩輪驅動,公司擬設立全資子公司湖北濟得藥業有限公司(暫定,以工商行政管理部門核准為準)。

公司名稱:湖北濟得藥業有限公司(暫定)經營範圍:生產經營大容量注射劑(玻瓶、軟袋)、生產直接接觸藥品內包裝材料(多層共擠輸液用袋)等;註冊資本金:2000萬元人民幣。

此次對外投資是為加強制劑業務板塊整合,提高資產運行效率,提升製劑產品市場競爭力,實現“原料藥+製劑”兩輪驅動,提高公司盈利能力和抗風險能力,促進公司業績增長。

此次對外投資設立全資子公司是公司從長遠戰略出發所做的慎重決策,子公司所從事業務為公司大輸液生產經營業務,屬於現有生產經營範疇,風險相對可控。公司將組建良好的子公司經營管理團隊,以不斷適應業務要求和市場變化,積極防範和應對各種風險。公司擬設立該全資子公司有利於提升公司經營管理效率,有利於增強公司綜合競爭力,符合公司的戰略發展方向,符合全體股東的利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account